Scholar Rock Holding sell stratec
Start price
27.10.20
/
50%
€20.60
Target price
04.11.21
-
Performance (%)
66.02%
End price
17.09.21
€34.20
Summary
This prediction ended on 17.09.21 with a price of €34.20. The SELL prediction by stratec for Scholar Rock Holding was trending in the completely wrong direction and closed with a performance of 66.02%. stratec has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Scholar Rock Holding | 5.147% | 5.147% | 113.433% | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by stratec for this prediction
In the thread Scholar Rock Holding diskutieren
Sell Scholar Rock Holding